Preliminary study of the safety and efficacy of donepezil hydrochloride in children with Down syndrome: A clinical report series

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Medical Genetics. Part A

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ajmg.a.31790PMID 17542008
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NEPSY: A Developmental Neuropsychological Assessment

  2008cited by this paper
• Clinical trials in children with Down syndrome: Issues from a cognitive research perspective

  2006cited by this paper
• Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.

  2006cited by this paper
• Safety and Efficacy of Rivastigmine in Adolescents with Down Syndrome: A Preliminary 20-Week, Open-Label Study

  2006cited by this paper
• Autoradiographic studies of neurotransmitter receptors in the brain of newborn infants with Down syndrome.

  2005cited by this paper
• Donepezil effects on language in children with Down syndrome: Results of the first 22‐week pilot clinical trial

  2004cited by this paper
• Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study

  2003cited by this paper
• Understanding mental retardation in Down's syndrome using trisomy 16 mouse models

  2003cited by this paper
• Donepezil for the treatment of language deficits in adults with Down syndrome: A preliminary 24‐week open trial

  2003cited by this paper
• The cholinergic basal forebrain system during development and its influence on cognitive processes: important questions and potential answers.

  2003cited by this paper
• Down syndrome and Alzheimer disease: response to donepezil.

  2002cited by this paper
• A 24‐week, double‐blind, placebo‐controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease—pilot study

  2002cited by this paper
• A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

  2001cited by this paper
• The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1

  1999cited by this paper
• Cholinergic therapy for Down's syndrome.

  1999cited by this paper
• Conners' rating scales-revised : technical manual

  1997cited by this paper
• A mouse model for Down syndrome exhibits learning and behaviour deficits

  1995cited by this paper
• [3H]vesamicol binding in human brain cholinergic deficiency disorders.

  1990cited by this paper
• Selective retardation of the development of the basal forebrain cholinergic and pontine catecholaminergic nuclei in the brain of trisomy 16 mouse, an animal model of Down's syndrome.

  1989cited by this paper
• Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease.

  1986cited by this paper
• Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.

  1983cited by this paper

• Differences in cholinergic terminal density in adults with Down syndrome compared to neurotypical controls measured by [18F]-fluoroethoxybenzovesamicol positron emission tomography imaging.

  2025cites this paper
• Age-Related Changes in the Cholinergic System in Adults with Down Syndrome Assessed Using [18F]-Fluoroethoxybenzovesamicol Positron Emission Tomography Imaging

  2024cites this paper
• Cholinergic System Structure and Function Changes in Individuals with Down Syndrome During the Development of Alzheimer's Disease.

  2024cites this paper
• Durable recovery from amblyopia with donepezil

  2023cites this paper
• Use of donepezil for neurocognitive recovery after brain injury in adult and pediatric populations: a scoping review

  2023cites this paper
• Effect of donepezil hydrochloride on the transgenic Drosophila expressing human Aβ-42

  2023cites this paper
• Pharmacotherapy of Traumatic Childhood Aphasia: Beneficial Effects of Donepezil Alone and Combined With Intensive Naming Therapy

  2020cites this paper
• Cognitive Functioning in Children with Down Syndrome: Current Knowledge and Future Directions.

  2019cites this paper
• Damasio, Antonio R. (1944–)

  2018cites this paper
• Adaptive behavior in adolescents and adults with Down syndrome: Results from a 6‐month longitudinal study

  2018cites this paper
• Challenges in measuring the effects of pharmacological interventions on cognitive and adaptive functioning in individuals with Down syndrome: A systematic review

  2017cites this paper
• Certainty of genuine treatment increases drug responses among intellectually disabled patients

  2017cites this paper
• Safety and efficacy of rivastigmine in children with Down syndrome: A double blind placebo controlled trial

  2016cites this paper
• Molecular Basis of Cholinergic Changes in Autism Spectrum Disorders and Relevance for Treatment Interventions

  2015cites this paper
• Desempenho de Escolares em Atenção e Funções Executivas no Nepsy e Inteligência

  2015cites this paper
• The Molecular Basis of Autism

  2015cites this paper
• Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young‐adult Ts65Dn and disomic mice

  2014cites this paper
• Diagnóstico prenatal no invasivo

  2014cites this paper
• Una "curación" para el síndrome de Down: ¿qué desean los padres?

  2014cites this paper
• C URRENT OPINION Prenatal treatment of Down syndrome: a reality?

  2014cites this paper
• A ‘cure’ for Down syndrome: what do parents want?

  2014cites this paper
• Prenatal treatment of Down syndrome: a reality?

  2014cites this paper
• A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia.

  2014cites this paper
• New therapies for treating Down syndrome require quality of life measurement

  2013cites this paper
• Effectiveness and Safety of Donepezil in Boys With Fragile X Syndrome

  2013cites this paper
• Therapeutic approaches in the improvement of cognitive performance in Down syndrome: past, present, and future.

  2012cites this paper
• Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: A pilot study

  2012cites this paper
• Discoveries in Down syndrome: moving basic science to clinical care.

  2012cites this paper
• Down syndrome, health and disability : a population-based case record and follow-up study

  2011cites this paper
• HERAPY FOR A UTISTIC S PECTRUM D ISORDERS : R EVIEW AND C ASE R EPORT

  2011cites this paper
• Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10–17

  2010cites this paper
• Chapter 23. Down Syndrome

  2010cites this paper
• Down syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21

  2010cites this paper
• The Synaptic Role of Neuronal Calcium Sensor 1 in Dentate Gyrus Plasticity, Curiosity and Spatial Memory

  2010cites this paper
• Cholinergic Component of Autism Spectrum Disorder

  2010cites this paper
• The emergence of pharmacotherapies for cognitive function in Down syndrome

  2010cites this paper
• The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome

  2009cites this paper
• Cholinesterase inhibitors and beyond.

  2009cites this paper
• Cognitive Enhancement Therapy for a Model of Down Syndrome

  2009cites this paper
• Psychiatric phenotypes associated with neurogenetic disorders.

  2009cites this paper
• Can Drug Treatments Enhance Learning in Subjects with Intellectual Disability?

  2009cites this paper
• Restoration of Norepinephrine-Modulated Contextual Memory in a Mouse Model of Down Syndrome

  2009cites this paper
• Cognition enhancers between treating and doping the mind.

  2008cites this paper
• Children with down syndrome: Implications for assessment and intervention in the school.

  2008cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2007cites this paper
• The effects of some nonsteroidal anti-inflammatory drugs on experimental induced gastric ulcers in rats

  2007cites this paper